Accessibility Menu
 
Rezolute logo

Rezolute

(NASDAQ) RZLT

Current Price$2.48
Market Cap$236.37M
Since IPO (2013)-100%
5 Year-68%
1 Year-26%
1 Month-32%

Rezolute Financials at a Glance

Market Cap

$236.37M

Revenue (TTM)

$0.00

Net Income (TTM)

$84.23M

EPS (TTM)

$-0.92

P/E Ratio

-2.67

Dividend

$0.00

Beta (Volatility)

0.69 (Low)

Price

$2.48

Volume

132,404

Open

$2.42

Previous Close

$2.48

Daily Range

$2.37 - $2.49

52-Week Range

$1.07 - $11.46

RZLT News

No articles available.

RZLT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rezolute

Industry

Biotechnology

Employees

71

CEO

Nevan Charles Elam

Headquarters

Redwood City, CA 94065, US

RZLT Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-74%

Return on Capital

-70%

Return on Assets

-61%

Earnings Yield

-37.45%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$236.37M

Shares Outstanding

95.70M

Volume

132.40K

Short Interest

0.00%

Avg. Volume

3.75M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$79.89M

EBITDA

$79.86M

Operating Cash Flow

$69.08M

Capital Expenditure

$0.00

Free Cash Flow

$69.08M

Cash & ST Invst.

$167.86M

Total Debt

$1.61M

Rezolute Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$7.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$236.37M

N/A

Market Cap/Employee

$3.69M

N/A

Employees

64

N/A

Net Income

$22.77M

-44.8%

EBITDA

$24.21M

-41.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$131.65M

+39.2%

Accounts Receivable

$600.00K

N/A

Inventory

$0.00

N/A

Long Term Debt

$619.00K

-53.6%

Short Term Debt

$666.00K

+11.2%

Return on Assets

-60.76%

N/A

Return on Invested Capital

-69.64%

N/A

Free Cash Flow

$20.32M

-48.7%

Operating Cash Flow

$20.32M

-48.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PROKProKidney Corp.
$1.93-1.03%
PRMEPrime Medicine, Inc.
$3.52-4.35%
KURAKura Oncology, Inc.
$8.26-2.02%
MRVIMaravai LifeSciences Holdings, Inc.
$2.98-1.65%

Trending Stocks

Symbol / CompanyPricePrice Chg
SMCISuper Micro Computer
$20.53-0.33%
NVDANvidia
$172.70-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%

Questions About RZLT

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.